Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
Stopped The study was terminated based on a non-safety related corporate decision.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
- DRUG: Tesamorelin
- DRUG: Placebo
Sponsor
Theratechnologies